| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 571,195 | 514,224 | 408,588 | 241,493 | | Cost of Revenue | 253,680 | 423,053 | 257,574 | 176,239 | | | Gross Profit | 317,515 | 91,171 | 151,015 | 65,254 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 197,217 | (12,940) | 72,973 | 13,870 | | Non Recurring | 274 | (142) | (132) | 43,521 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 144,488 | 104,254 | 78,174 | 7,862 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 910 | 234 | 446 | 144 | | Earnings Before Interest And Taxes | 130,414 | 112,523 | 84,948 | 38,544 | | Interest Expense | 5,187 | 4,759 | 4,396 | 2,104 | | Income Before Tax | 125,228 | 107,763 | 80,552 | 36,439 | | Income Tax Expense | 61,375 | 35,733 | 26,795 | 11,892 | | Minority Interest | (1,029) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 86,668 | 72,030 | 53,757 | 24,548 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 62,824 | 72,030 | 53,757 | 24,548 | | Preferred Stock And Other Adjustments | 637 | (403) | (234) |
-
| | | Net Income Applicable To Common Shares | $63,461 | $71,627 | $53,523 | $24,548 |
|
0.20% Nasdaq 
Income Statement
